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Abstract: Dietary supplements and functional foods are becoming increasingly popular complements
to regular diets. A recurring ingredient is the essential cofactor vitamin B12 (B12). Microalgae are
making their way into the dietary supplement and functional food market but do not produce B12,
and their B12 content is very variable. In this study, the suitability of using the human B12-binding
protein intrinsic factor (IF) to enrich bioavailable B12 using microalgae was tested. The IF protein was
successfully expressed from the nuclear genome of the model microalga Chlamydomonas reinhardtii
and the addition of an N-terminal ARS2 signal peptide resulted in efficient IF secretion to the medium.
Co-abundance of B12 and the secreted IF suggests the algal produced IF protein is functional and
B12-binding. Utilizing IF expression could be an efficient tool to generate B12-enriched microalgae in
a controlled manner that is suitable for vegetarians and, potentially, more bioavailable for humans.
Keywords: Chlamydomonas; vitamin B12; cobalamin; intrinsic factor; microalgae; nuclear
transformation; recombinant protein; dietary supplements; functional foods
1. Introduction
There is an increasing awareness of the effect of diet on human health and, in particular, in the
development of illness and chronic disease. This has led to an upward trend in consumer demand for
naturally occurring bioactives that can be delivered in the form of dietary supplements or incorporated
into functional foods. One of the common bioactives is vitamin B12.
Vitamin B12 or cobalamin (B12), is an essential cofactor produced by certain prokaryotes via two
main complex biosynthetic pathways [1]. In humans, B12 is an essential cofactor required for a range
of cellular metabolism functions (e.g., DNA synthesis and methylation, mitochondrial metabolism) [2].
B12 uptake and transport from ingestion to the blood stream is a multi-step complex pathway [3].
One of the proteins playing a key role in this process is the human protein intrinsic factor (IF).
The glycoprotein binds free B12 in the ileum and the IF-B12 complex is then recognized by the cubam
receptor complex facilitating receptor-mediated endocytosis [4]. The lack of a functional IF protein
leads to the severe autoimmune disease pernicious anaemia [3]. Less severe but rather common cases
of B12 deficiency are typically found in children, pregnant women and the elderly. Vegetarians and
vegans are also at a higher risk for B12 deficiency, as higher plants do not produce or uptake B12 and
are, therefore, not a dietary source of B12 [5]. To counteract the lack of dietary B12 intake, a wide range
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of supplements are commercially available. For instance, microalgal Chlorella supplements were found
to contain amounts of B12 varying from trace amounts up to 415 µg per 100 g dry weight [6].
Microalgae are versatile, unicellular photosynthetic organisms that are attracting increasing
attention. Despite edible microalgae having a long tradition as a food source, large scale cultivation
has only become widespread since the middle of last century [7,8]. Potential exploitations of
microalgae are as diverse as the polyphyletic group itself. In the context of this study, three main
applications should be mentioned: (I) microalgae for functional foods (due to their high protein content,
anti-oxidative properties and other potential health benefits) and as a vegetarian source of bioactive
supplements [9–11]; (II) microalgae as a novel recombinant biotechnological host [12–15]; and (III)
microalgae as a source of natural high-value compounds (recently reviewed in [12,16]).
These themes of microalgal applications are brought together in this proof-of-concept study by
testing the possibility of enriching B12 in microalgae using the human IF protein. To this end, nuclear
transformants of the green model alga Chlamydomonas reinhardtii expressing IF were generated. The IF
protein was successfully expressed and the addition of a signal peptide from arsylsulfatase resulted in
the efficient secretion of IF to the medium. The supplementation of the culture medium with B12 led to
a higher IF abundance in the generated microalgal strains. This proof-of-concept shows microalgae are
a viable host for the production of a vegetarian IF source for B12 enrichment. This could pave the way
for developing a vegetarian source of bioavailable B12 for dietary supplements and the enrichment of
functional foods.
2. Materials and Methods
2.1. Construct Design and Plasmid Construction
The amino acid sequence of the human intrinsic factor (Uniprot KB: P27352) was codon-optimized
for nuclear expression in the green alga C. reinhardtii using the software GeneDesigner 2.0 (Atum,
Newark, CA, USA) [17]. The N-terminal native signal peptide (amino acid sequence (AA) 1–18)
was removed and a C-terminal human influenza hemagglutinin (HA) epitope tag (AA sequence:
YPYDVPDYA) was added for detection of the protein. Additionally, a second construct was made
with an N-terminal secretion signal peptide of the C. reinhardtii native arsylsulfatase ARS2 (AA 1–21,
Uniprot KB: Q9ATG5) [18]. The synthetic genes were custom synthesized by Genscript (Piscataway,
NJ, USA) and cloned into the pCrEX1 nuclear expression vector (based on pSR108 [19]) using the
restriction sites SapI (LguI) and BglII. Figure 1 gives an overview of the expression cassettes. The correct
construct assembly has been verified by sequencing. All plasmids were amplified in Escherichia coli
DH5α and purified for transformation of C. reinhardtii.
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Figure 1. Overview of the intrinsic factor (IF) expression cas ettes used for C. reinhardtii transfo mation.
The strains expressing the constructs hav been named “IF” a d “ars-IF” respectively. The 3′ and 5′
untranslated regions of the C. reinhardtii PSAD gene are used for gene expression. (a) The N-terminal
native signal peptide of the human IF protein was removed and the full length protein was
codon-optimized for C. reinhardtii nuclear expression. A C-terminal human influenza hemagglutinin
(HA) epitope tag was added to the protein for detection purposes. (b) Additionally, a second version
of IF was constructed with the secretion signal peptide of arsylsulfatase ARS2.
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2.2. Strains and Cultivation Conditions
The C. reinhardtii strain CC-849 (cw10, mt−) was obtained from the Chlamydomonas Resource
Center (University of Minnesota, Minneapolis, MN, USA). All strains were maintained at 25 ◦C and
approximately 50 µE continuous illumination on 2% Tris-Acetate-Phosphate (TAP) medium [20] agar
plates with a modified trace element recipe [21]. Liquid cultures were grown in TAP medium at
25 ◦C, 110 rpm shaking and approximately 100 µE continuous illumination. When TAP medium was
supplemented with vitamin B12 (20–100 µg·L−1), commercially obtained cobalamin (Sigma-Aldrich,
Dorset, United Kingdom) was added from a 0.1 g·L−1 stock solution.
Initial screens for positive transformants were performed in 24 well plates. The wells were
inoculated with single colonies and grown for 5 days before analysis. For protein expression analysis,
100 mL pre-cultures were inoculated from a plate. After 6 days, 100 mL cultures were re-inoculated to
an OD750 of 0.01. Cells were subsequently harvested at mid to late log phase. For protein concentration
and B12 assays, 1 L cultures were inoculated to an OD750 = 0.02 from a 1 week-old 100 mL pre-culture
and grown to a mid-log phase stage before processing.
2.3. Nuclear Transformation
For nuclear transformation, 1 µg of the respective plasmid was linearized by cutting with EcoRI.
A nuclear glass-bead transformation protocol was used based on a previously described method [22,23].
In brief, a 200 mL culture of CC-849 was grown to early log-phase and resuspended in 2 mL fresh
TAP medium. Per transformation, 300 µL concentrated cells and 1 µg of linearized plasmid were
used. The cell-DNA mixture was added to approximately 300 mg 400–600 µm acid-washed glass
beads (Sigma-Aldrich, Dorset, United Kingdom) and agitated on a vortex for 15 s on maximum speed.
The cells were diluted with TAP medium to a final volume of 10 mL and grown for approximately 18 h.
After resuspension of the cell pellets in 500 µL TAP medium, soft agar (0.5%) was added and the mixture
spread on TAP plates containing 10 µg·mL−1 Zeocin (InvivoGen, Toulouse, France) for selection of
transformants that incorporated the construct containing the ble marker [19]. After approximately
8 days, colonies were re-streaked and subsequently analyzed for the presence of the gene of interest.
2.4. PCR Analysis
Transformant colonies were screened for the presence of the gene of interest using polymerase
chain reaction (PCR). A gene fragment was amplified from genomic DNA using a standard protocol
with Phire Plant Direct Master Mix (Thermo Fisher Scientific, Loughborough, United Kingdom).
The following primers were used to amplify a 600 base pair fragment confirming the presence
of the IF/ars-IF expression cassette: IF-fragF (5′-3′) CAGCATGAAGATTAAGGACA and IF-fragR
(5′-3′) GTAGTACTGCGTGAAGTTG.
2.5. Preparation of Cellular Lysates and Medium Samples for Protein Expression Analysis
For protein expression analysis, cultures were grown as indicated in Section 2.2. Cellular lysates
were prepared by resuspending an equivalent of OD750 = 1 cells in mid to late log phase in 100 µL
10 mM Tris-HCl (pH 8.0). To analyze the medium, 1 mL of culture was spun down at 20,000× g for
5 min and the cleared supernatant transferred to a separate tube.
2.6. Protein Concentration and Ion Exchange Chromatography
1 L mid-log phase cultures were harvested at 4000× g for 20 min at 4 ◦C. For protein concentration
from the medium, the culture supernatant was filtered through Whatman filter paper to remove any
debris and subsequently through a 0.2 µm membrane to remove any residual cells. The pre-purified
medium fraction was subsequently loaded on the column.
For concentration of cellular proteins, the harvested cells were resuspended in lysis buffer (20 mM
Tris-HCl (pH 7.2), 5% glycerol, 20 µg·mL−1 DNaseI (Roche, Mannheim, Germany), EDTA-free protease
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inhibitor (Roche)) and sonicated (3 cycles of 30 s sonication and 30 s on ice). The lysate was cleared by
ultracentrifugation (Beckmann TLA-100.3 rotor (Beckman, Lismeehan, Ireland), 70,000 rpm, 30 min)
and the soluble supernatant loaded on the column.
For ion exchange chromatography, 10 mL columns (Q Sepharose Fast Flow, GE Healthcare, Little
Chalfont, United Kingdom) were freshly prepared for each purification. A vacuum pump was used
to pass the medium samples through the column. After loading of the sample (medium or cellular
lysate), the column was washed with a Tris based buffer (20 mM Tris-HCl (pH 7.2), 5% glycerol, 1 mM
MgCl2, 5 mM dithiothreitol) containing 50 mM NaCl. Protein fractions were then eluted with buffer
containing rising concentrations of NaCl (100 mM, 150 mM, 200 mM, 300 mM, 400 mM and 1 M NaCl).
2.7. Vitamin B12 Assay
The bioassay for the detection of B12 content in the protein fractions from ion exchange
chromatography is based on the Salmonella enterica serovar Typhimurium LT2 strain AR2680 (metE–,
cbiB–). Details of the assay are described elsewhere [24]. In very brief, this Salmonella strain cannot
synthesize B12 de novo (CbiB–) and has no B12-independent methionine synthase (MetE–). Thus,
growth of this strain is dependent on an external source of vitamin B12 as a co-factor for the vitamin
B12-dependent methionine synthase MetH. The plaque size (growth) is dependent on the amount of
externally supplemented vitamin B12, and can thus be used to semi-quantify Vitamin B12 levels in the
sample. A calibration curve using 10 µL of 0.001 µM, 0.01 µM, 0.1 µM and 1 µM B12 solutions led to
the equation used to calculate the B12 content in the analyzed samples:
vitamin B12 concentration (µM) = 0.0029 × (plaque diameter in cm)5.4616 (1)
Unpaired Student’s t-tests were performed using the software Prism (version 7.0, GraphPad
Software, La Jolla, CA, USA). Values were considered statistically significant for p < 0.05.
2.8. Reducing SDS-PAGE, Native PAGE and Western Blotting
Samples were separated by electrophoresis on 12% polyacrylamide gels using a Bio-Rad Mini
Protean Gel system (Bio-Rad Laboratories, Watford, United Kingdom). For reducing, denaturing
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), samples were boiled with
Laemmli buffer containing β-mercaptoethanol at 95 ◦C for 5 min (crude cellular lysates and medium
samples) or 10 min at 50 ◦C (fractions from ion exchange chromatography). For native analysis,
samples were not boiled and no sodium dodecyl sulfate nor β-mercaptoethanol was used in samples,
gels or running buffer. The polyacrylamide gels were subsequently immunoblotted using antibodies
against the C-terminal HA-tag (Sigma-Aldrich, Dorset, United Kingdom) and against the C-terminus
of the IF protein (abcam) to detect the protein of interest.
2.9. Densitometric Analysis
Densitometry analysis of immunoblots was performed using ImageLab Software Version 4.1
(Bio-Rad Laboratories, Watford, United Kingdom). The relative abundance of the IF protein was
calculated in relation to the protein band found without supplementation of B12 to the medium. For the
ars-IF strains, the calculated abundance was normalized to the OD750 of the cultures measured at
harvesting to account for growth differences. This correction was not performed for the IF strains as
equal amounts of cellular lysate standardized to OD750 were loaded on the gel.
3. Results
3.1. Generation of C. reinhardtii Nuclear Transformants “IF” and “ars-IF”
For this study, constructs for nuclear transformation of a wall-deficient C. reinhardtii strain
(CC-849) were assembled with the human gene encoding the mature sequence of the B12-binding
protein IF flanked by 5′ and 3′ untranslated regions (UTRs) of the PSAD gene. Two constructs
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were generated—one for cytoplasmic expression (Figure 1a) encoding IF and a second version
with the addition of an N-terminal signal peptide from ARS2 (Figure 1b). This signal peptide has
previously been shown to enable secretion to the medium in C. reinhardtii of recombinant proteins [18].
Additionally, a C-terminal HA epitope tag was added to both proteins for detection purposes. The ble
marker downstream of the gene of interest on the pCrEX1 plasmid was used to select for positive
transformants after transformation by agitation of a DNA-cell mixture with glass beads (modified from
previously described methods [22,25], see Section 2.3). The presence of the IF cassette was verified
by PCR (Figure S1) in colonies that grew on Zeocin after transformation. Positive candidates based
on PCR results were then subjected to immunoblot analysis to screen for expression of the IF protein.
Two strains with the respective constructs were found to express detectable levels of IF (Figure 2).
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Figure 2. Expression f human intrinsic factor (I ) r t i and ars-IF in C. reinhardtii CC-849 detected
by immunoblot analysis using HA (αHA) and i i factor (αIF) antibodies, respectively, in the
culture medium and cellular lysates. (a) Cellular lysate of IF strain expr ssing the protein. The protein
band is indicate with an arrow (IF). A second, non-specific band cross-reacting with the HA antiserum
is indicated (N.S.). (b) Culture supernatant (medium) of transfor ed CC-849 strain expressing ars-IF.
‘C’ indicates a negative control (cellular lysate and supernatant of the untransformed CC-849 strain).
(c) Cellular lysates of ars-IF strain and CC-849. (d) Culture medium of ars-IF and IF strain.
3.2. Expression of Human Intrinsic Factor in C. reinhardtii
The expected size of the mature size IF based on its amino acid sequence is 44.6 kDa. The IF protein
expressed in the IF strain has a similar size migrating on an SDS-PAGE slightly faster than the 46 kDa
molecular weight standard (Figure 2a). Additionally, a s cond non-sp cific band cross-reacting with
the HA antiserum was detected in c llular lysates of both, the IF and the control strain around 32 kDa
that we previously observe in C. reinhardtii cellular lysates [26]. The IF protein was expressed with an
N-terminal ARS2 signal peptide in the ars-IF strain. The signal peptide and the mature IF protein have
a combined predicted molecular weight of 46.3 kDa, however, the expected size of the mature protein
after cleavage of the ARS2 signal peptide is the same molecular weight as the cytoplasmic IF protein
with 44.6 kDa (this observation is discussed in more detail in Section 4.2). Immunoblot analysis of the
ars-IF culture medium shows the protein migrating at a size around 50 kDa which is slightly bigger
than expected. To further verify the band, which is not present in the CC-849 control strain (Figure 2b),
the protein was also immunoblotted using an IF-specific antibody. With both antibodies, the same
band was detected.
To determine the localization of the protein, culture supernatant (medium) and pelleted cells
(cellular lysate) were immunoblotted separately. In the IF strain, the IF protein was only detected in
cellular lysates (Figure 2a,d). In contrast to this, the IF protein expressed in the ars-IF strain with the
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ARS2 signal peptide was only found in the culture supernatant (Figure 2b), no protein was detected in
cellular lysates (Figure 2c).
3.3. C. reinhardtii-Produced IF Stability Increases with External Vitamin B12 Supplementation
To test the B12 binding capacities of the microalgal IF produced protein, the IF and ars-IF strains
were grown in TAP medium supplemented with vitamin B12 at a concentration of 0, 20, 50 and
100 µg·L−1. As shown by immunoblotting, a correlation between higher B12 levels and the IF protein
(ars-IF strain) in the medium is observed (Figure 3a). The protein abundance increases approximately
2.1 fold (±0.50) with the addition of 100 µg·L−1 B12 in the culture medium (Table 1). Similarly, based
on densitometric analysis of relative protein abundance, the cytoplasmic IF protein in the IF strain is
also estimated to be more abundant with B12 supplemented in the medium. However, here the highest
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Figure 3. Accumulation of human i trinsic factor (IF) protein i C. reinhardtii ars-IF and IF cult res with
increasing once trations of v tamin B12 (cobalamin) supplemented TAP medium. (a) HA-immunoblot
of medi m harvest from CC-849 and ars-IF cultures grown to late l g phase contai ing 0, 20,
50 and 100 µg·L−1 Vitamin B12. Equal mounts of culture s t (20 µL) loaded per lane.
(b) HA-immunobl t f cellular lysates from C -849 and IF cultures grown to late log phase ith 0, 20,
50 and 100 µg·L−1 Vitamin B12 supplemented. Equal amounts of cellular lysate standardize by OD750
loaded. Mobility of IF protein indicated by arrow, N.S. denotes a non-specific protein cross-reacting
with the HA-serum. Supplementary Figure S2 shows Coomassie stained SDS-polyacrylamide gels with
total protein loaded for respective western blot samples.
Table 1. Relative human intrinsic factor (IF) protein expression levels in IF and ars-IF strains for
different B12 concentration supplemented to growth medium (n = 3 ± standard error).
Vitamin B12 in Medium (µg·L−1) ars-IF Strain (Medium) 1 IF Strain (Cytoplasmic) 2
0 1.0 1.0
20 1.1 ± 0.01 1.4 ± 0.15
50 1.6 ± 0.17 2.3 ± 0.17
100 2.1 ± 0.50 1.4 ± 0.11
1 Densitometric relative quantity of IF was normalized to the OD750 of the respective cultures measured when
samples were harvested. 2 Equal amounts of cells, normalized to OD750, for all cultures were loaded on gel
for immunoblotting.
3.4. Correlation of Vitamin B12 and IF Protein Levels
To further investigate if the IF protein was binding B12, the protein was concentrated from cellular
lysates (IF strain, CC-849 control) and the medium (ars-IF strain, CC-849 control). Ion exchange
chromatography was used to concentrate and separate protein fractions from total cellular (IF strain)
or secreted protein (ars-IF). Protein fractions were eluted with rising NaCl concentrations from 100 mM
to 1 M NaCl. Both IF expressing strains and the negative control strain CC-849 were grown with either
no B12 or 20 µg·L−1 B12 supplemented to the medium. The majority of the IF protein was eluted with
100–150 mM NaCl in both cases, the medium and the cytoplasmic IF version, as shown by immunoblot
analysis of the individual protein fractions (Figure 4). Immunoblots of IF concentrated from cellular
lysates of the IF-strain showed one prominent band of the protein with both reducing SDS-PAGE and
native PAGE (Figure 4a). In the medium version, bands migrating differently in native PAGE than
with reducing SDS-PAGE were observed (Figure 4b).
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Figure 5. Vitamin B12 ntent of protein fractions purified from IF and ar -IF strains grown with
20 µg·L−1 suppl mented TAP ediu d termined using a plaque assay of Salmonella nterica (metE–
cbiB–). Fractions wer eluted with i creasing concentrations of NaCl (100 mM to 1 M). Data show
average values, error bars: standard error (n = 3). Statistically significant differences between the control
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(a) B12 amounts detected in fractions of 1 L cellular lysates from IF and CC-849 strains. (b) B12 amounts
detected in protein fractions purified from 1 L medium of ars-IF or CC-849 cultures.
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4. Discussion
4.1. Expression and Efficient Secretion of a Human Glycoprotein Intrinsic Factor in Microalgae
In this study we have successfully expressed the human B12 receptor protein IF in C. reinhardtii.
The protein was expressed from the nuclear genome as this allowed for secretion of the protein to
the medium and potential glycosylation of the protein. Two different strains were generated for this
study—one strain expressing the 44.6 kDa IF protein in the cytoplasm (IF-strain) and a second strain
that secretes the protein to the medium (ars-IF). The ars-IF expressed IF protein has been found to
be efficiently secreted to the medium by means of an ARS2 signal peptide that has previously been
used to secrete a recombinant enzyme [18]. No protein was detected in the cellular lysate in the ars-IF
strain (Figure 2c). This suggests more efficient secretion of the ars-IF than what has been reported for
secretion of a luciferase using the same ARS2 signal peptide [18]. To date, only few studies on the
secretion of recombinant proteins in microalgae are available. Most reports are from the green alga
C. reinhardtii [18,27–30] or the diatom Phaeodactylum tricornutum [31,32].
4.2. Posttranslational-Modification of the Secreted IF Protein
Based on migration on SDS-PAGE gels, the secreted microalgal IF protein showed a consistently
larger molecular size compared to the cytoplasmic protein (Figures 3, 4 and 5b,c). There are several
reasons that could explain this. One possibility is the failure to cleave the signal peptide. However,
the ARS2 signal peptide only adds approximately 1.7 kDa to the mature protein which seems unlikely
to cause the observed shift of around 5 to 10 kDa. A previous study has used an ARS1 signal peptide
for secretion of a protein to the medium and observed a similar pattern. In this study, the signal
peptide was not found with mass fingerprint analysis suggesting that the non-cleavage of the signal
peptide was unlikely [18].
Another possibility that could explain the size difference is the post-translational modification
of the IF protein. This is likely as the human IF protein contains an N-glycosylation site [33] and is
known to be highly glycosylated. When previously expressed in higher plants (Arabidopsis thaliana)
glycosylation was observed and the protein detected had a similar size of 50 kDa to the algal expressed
IF [34]. The glycosylation of IF seems to be non-essential for B12 and receptor binding [35], however,
it may stabilize and protect the protein from degradation in the low pH and proteolytic conditions in
the intestine. Not much is known about N-glycosylation in Chlamydomonas [27,36,37] and efforts to
characterize the secreted IF protein in more detail were prevented by low expression levels. Treatment
of the protein with a commercial deglycosylation enzyme cocktail (Protein Deglycosylation Mix II,
New England Biolabs, Hitchin, United Kingdom) was inconclusive and we did not obtain sufficient
amounts of pure protein for mass spectrometry (data not shown) from 1 L cultures (OD750nm between
0.6 and 0.8). Low expression levels of recombinant proteins are to date a common problem seen in
Chlamydomonas (previous studies have reported 0.25% of total cellular protein [38] or 0.25% of total
soluble protein [30] for example). This is likely due to various factors such as random insertion of the
construct in the nuclear genome and efficient silencing mechanisms [39]. Recent efforts to establish
targeted DNA approaches (see [14,40] for recent reviews) such as CRISPR/Cas9 technology [41–43] for
nuclear transformation in C. reinhardtii could be promising tools to increase recombinant protein yields
allowing for a more detailed characterization of the algae-produced IF protein.
4.3. Vitamin B12 Enrichment in IF Expressing C. reinhardtii Strains
Eukaryotic microalgae do not produce B12 and more than half of microalgal species are thought
to be B12 auxotrophs relying on B12 obtained from symbiotic relationships with bacteria [44,45].
The model alga C. reinhardtii used in this study has been shown to be B12 independent as it contains
METE (B12-independent methionine synthase gene). However, the alga also contains the B12-dependent
B12 methionine synthase MetH which is preferably used in the presence of B12 [44].
Biology 2018, 7, 19 9 of 13
No B12 was detected in any protein fractions concentrated from cultures grown without B12
supplementation (Table S1) which is expected as the algae were grown axenically. When supplementing
the medium with B12, increased amounts of the IF protein were detected in both strains, IF and ars-IF
(Figure 3 and Table 1). This indicates that the IF protein is stabilized due to B12 binding. IF is a known
B12 binding protein and formation of the holo-IF form stabilizes the protein [33]. Binding of B12 to the
cytoplasmic IF protein presumes the cellular uptake of B12 from the medium into the cell. B12 transport
into the cell in Chlamydomonas is existent, evident by their ability to utilize B12 [44,46] but molecular
mechanisms of B12 uptake in microalgae have hardly been described [47]. The semi-quantitative
B12 assay shows a significant difference of the total B12 amount accumulated in the IF strain lysates
compared to a negative control strain (Figure 5a). However, this observation was not supported by the
individual elution fractions. If the increased amount of B12 found in the IF lysates was directly due to
binding to the IF protein, one would expect to see a significant difference in the elutions containing
the majority of the IF protein (100 mM, 150 mM NaCl, Figure 4). However, no significant differences
of any of the elution fractions were found for the IF and CC-849 control strain. Consequently, it is
possible that the expression of IF in the algae does lead to an enrichment of intracellular vitamin B12,
but further work is needed to support this hypothesis.
With the ars-IF strain, the IF protein was purified from the medium where the background from
other co-purified proteins is significantly lower than in the cellular lysates. Here, the fractions that
contain the highest amount of IF protein show a significantly higher B12 content when compared with
the control strain CC-849 (Figure 5b).
We also observed that, in the flow-through and the wash fractions (Figure 5b), no significant
differences between the ars-IF and the control strain is seen. This is likely to be due to the unbound B12
washing off and the B12 detected in subsequent elution fractions most likely being bound to protein.
However, the B12 bioassay used in this study does not allow distinguishing between protein-bound
B12 and free B12. Therefore, we cannot conclude if the B12 was bound to the secreted IF protein.
In the case of the cytoplasmic IF protein, there is a statistically significant difference between B12
concentrations measured in cellular lysates expressing IF and the control strain (Figure 5a). However,
there was no significant difference observed in the elution fractions. One reason for this might be
that the assay does not distinguish between B12 bound to the IF protein or other cellular proteins.
Other enzymes already known to be associated with intracellular B12 metabolism in algae will most
likely interact with internalized B12 [45]. This could explain the high background found in the protein
elutions from both cellular lysates, CC-849 and IF strain (Figure 5a). Additionally, a relative decrease of
cytoplasmic IF was observed from cultures supplemented with 50 µg·L−1 B12 to cultures supplemented
with 100 µg·L−1 B12 (Figure 3b and Table 1). Although we can only hypothesize, this decrease could
be due to concentration-dependent toxicity of the protein and therewith associated cellular regulatory
processes. Additionally, due to the random insertion of the expression cassette in the nuclear genome,
there is the possibility that other cellular functions may be affected.
4.4. Intrinsic Factor for Developing B12-Enriched Microalgae
In this study we expressed IF in the eukaryotic microalgae Chlamydomonas exploring the potential
of enriching bioavailable B12 using a microalgal host. We propose that this model alga could be a good
chassis for future production of microalgal functional foods and dietary B12 containing supplements.
For example, recently it has been shown that cyanobacteria produce a different chemical variant of
B12 [48]. This chemical variant of B12 (also known as pseudocobalamin) binds with a much lower
affinity to B12 receptor proteins such as IF making it less bioavailable for humans [49]. Eukaryotic
microalgae, on the other hand, utilize the same B12 variants as humans, therefore, making them a
better source of B12 supplementation.
As shown recently for Chlorella supplements [6], currently available eukaryotic microalgal
supplements can contain varying amounts of B12. This is most likely due to different cultivation
conditions altering the composition of the associated bacterial biofilms that are the original source of
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B12 found in the supplements. In this respect, the establishment of closed, standardized growth systems,
as previously shown for Chlamydomonas [50,51], allows for much more control over contamination
compared to open systems and hereby also of the B12 content in the final product. In addition, efforts to
engineer microalgal communities (reviewed recently in [12,52]) with symbiotic relationships, as found
between Mesorhizobium loti and Lobomonas rostrata [53,54], could allow for a more controlled interaction,
and thus flux of B12, of the microalga and associated bacteria. Finally, looking at the current market, IF,
of animal (porcine) origin, is commercially available in some B12 supplements. This proof-of-concept
study shows that microalgae are a potential vegetarian-friendly alternative to IF-B12 co-formulation in
functional foods and dietary supplements.
5. Conclusions
Here we have shown that the human glycoprotein Intrinsic Factor can be expressed in
Chlamydomonas reinhardtii from the nuclear genome. The addition of an ARS2 signal peptide leads
to efficient secretion to the medium. Our data suggest that the secreted IF protein directly binds
B12, however, it is less clear if the cytoplasmic IF binds the cofactor or has an indirect effect on
B12 enrichment in the IF strain. Our data also show a correlation of higher protein levels with
higher B12 concentrations suggesting a potential stabilizing effect on the protein. This study is a first
proof-of-concept utilizing a human B12 binding protein as a tool for enriching B12 in microalgae and
can contribute to the future development of microalgal functional foods.
Supplementary Materials: The following are available online at www.mdpi.com/2079-7737/7/1/19/s1,
Figure S1: PCR analysis of Chlamydomonas reinhardtii strains IF and ars-IF. Figure S2: Coomassie-stained
polyacrylamide gels of samples shown in Figure 3. Figure S3: IF purified from cultures grown without B12
supplementation. Table S1: Vitamin B12 assay plaque diameters measured in different fractions from ion exchange
chromatography and calculated Vitamin B12 content of samples (nM).
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